Segment Information (Tables)

3 Months Ended

Sep. 30, 2012

Three Months Ended September 30, 2012 and 2011:

	Human Health		Pharmaceutical Ingredients		Performance Chemicals		Unallocated Corporate			Consolidated Totals
2012
Net sales	$	26,409	$	40,608	$	44,731	$	-		$	111,748
Gross profit		8,103		6,576		6,826		-			21,505
Income before income taxes		3,119		2,553		3,085		(1,135	)		7,622

2011
Net sales	$	22,753	$	42,309	$	36,255	$	-		$	101,317
Gross profit		6,591		6,772		5,156		-			18,519
Income before income taxes		2,551		2,880		1,590		(2,282	)		4,739

- Definition

Tabular disclosure of the profit or loss and total assets for each reportable segment. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss.

+ References+ Details